» Articles » PMID: 30607369

Epigenetic Changes Around the PX Region and Spontaneous HTLV-1 Transcription Are CTCF-independent

Overview
Date 2019 Jan 8
PMID 30607369
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The human retrovirus HTLV-1 inserts the viral complementary DNA of 9 kb into the host genome. Both plus- and minus-strands of the provirus are transcribed, respectively from the 5' and 3' long terminal repeats (LTR). Plus-strand expression is rapid and intense once activated, whereas the minus-strand is transcribed at a lower, more constant level. To identify how HTLV-1 transcription is regulated, we investigated the epigenetic modifications associated with the onset of spontaneous plus-strand expression and the potential impact of the host factor CTCF. Patient-derived peripheral blood mononuclear cells (PBMCs) and in vitro HTLV-1-infected T cell clones were examined. Cells were stained for the plus-strand-encoded viral protein Tax, and sorted into Tax and Tax populations. Chromatin immunoprecipitation and methylated DNA immunoprecipitation were performed to identify epigenetic modifications in the provirus. Bisulfite-treated DNA fragments from the HTLV-1 LTRs were sequenced. Single-molecule RNA-FISH was performed, targeting HTLV-1 transcripts, for the estimation of transcription kinetics. The CRISPR/Cas9 technique was applied to alter the CTCF-binding site in the provirus, to test the impact of CTCF on the epigenetic modifications. Changes in the histone modifications H3K4me3, H3K9Ac and H3K27Ac were strongly correlated with plus-strand expression. DNA in the body of the provirus was largely methylated except for the pX and 3' LTR regions, regardless of Tax expression. The plus-strand promoter was hypomethylated when Tax was expressed. Removal of CTCF had no discernible impact on the viral transcription or epigenetic modifications. The histone modifications H3K4me3, H3K9Ac and H3K27Ac are highly dynamic in the HTLV-1 provirus: they show rapid change with the onset of Tax expression, and are reversible. The HTLV-1 provirus has an intrinsic pattern of epigenetic modifications that is independent of both the provirus insertion site and the chromatin architectural protein CTCF which binds to the HTLV-1 provirus.

Citing Articles

Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review.

Letafati A, Mehdigholian Chaijani R, Edalat F, Eslami N, Askari H, Askari F Clin Epigenetics. 2025; 17(1):39.

PMID: 40025589 PMC: 11871821. DOI: 10.1186/s13148-025-01841-z.


Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9.

Domingues W, Folgosi V, Sanabani S, Leite Junior P, Assone T, Casseb J Rev Inst Med Trop Sao Paulo. 2024; 66:e48.

PMID: 39194140 PMC: 11348795. DOI: 10.1590/S1678-9946202466048.


Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis.

Joseph A, Cheng X, Harding J, Al-Saleem J, Green P, Veis D bioRxiv. 2024; .

PMID: 38853836 PMC: 11160593. DOI: 10.1101/2024.05.28.596170.


The impact of HTLV-1 expression on the 3D structure and expression of host chromatin.

Yaguchi H, Melamed A, Ramanayake S, Kiik H, Witkover A, Bangham C PLoS Pathog. 2024; 20(3):e1011716.

PMID: 38427693 PMC: 10936777. DOI: 10.1371/journal.ppat.1011716.


The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle.

Aristodemou A, Rueda D, Taylor G, Bangham C PLoS Pathog. 2023; 19(7):e1011494.

PMID: 37523412 PMC: 10431621. DOI: 10.1371/journal.ppat.1011494.


References
1.
Majone F, Jeang K . Clastogenic effect of the human T-cell leukemia virus type I Tax oncoprotein correlates with unstabilized DNA breaks. J Biol Chem. 2000; 275(42):32906-10. DOI: 10.1074/jbc.C000538200. View

2.
Iwanaga R, Ohtani K, Hayashi T, Nakamura M . Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene. 2001; 20(17):2055-67. DOI: 10.1038/sj.onc.1204304. View

3.
Koiwa T, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Watanabe T . 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol. 2002; 76(18):9389-97. PMC: 136445. DOI: 10.1128/jvi.76.18.9389-9397.2002. View

4.
Lemasson I, Polakowski N, Laybourn P, Nyborg J . Transcription regulatory complexes bind the human T-cell leukemia virus 5' and 3' long terminal repeats to control gene expression. Mol Cell Biol. 2004; 24(14):6117-26. PMC: 434238. DOI: 10.1128/MCB.24.14.6117-6126.2004. View

5.
Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A . Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology. 2005; 2:64. PMC: 1289293. DOI: 10.1186/1742-4690-2-64. View